POST-GRADUATE TRAINING

UT Southwestern Mohs Micrographic Surgery Fellowship; Dallas, TX                July 1, 2022 – present

Stanford Dermatology Residency Program; Redwood City, CA                                 July 1, 2019 – 2022

Signature Healthcare, Beth Israel Deaconess Internship Program;                       June 23, 2018 – 2019

Brockton, MA                                                                                                         

BOARD CERTIFICATION

Diplomate of the American Board of Dermatology                                Examination date: July 22, 2022

WORK EXPERIENCE

DirectDerm; Manteca, CA                                                                            November 2021 – May 2022

Moonlighting experience during my PGY-4 year at Stanford. I treated an average of 26-35 general dermatology patients over a 7 hour workday. Supervising attending: David Wong, MD, PhD

LEADERSHIP POSITIONS

Chief Resident, Stanford Dermatology Residency Program                                    March 1, 2021 - 2022

EDUCATION & AWARDS

Tufts University School of Medicine (TUSM); Boston, MA                          Aug 13, 2013 – Apr 20, 2018

Doctor of Medicine with Research Honors (Awarded May 20, 2018)
- William Dameshek Award in Research (2018)                                                                                    

- George L. Howland Award in Anatomy (2018)                                                                                   

- Alpha Omega Alpha Honor Society (2017)                                                                                           

Tufts Clinical & Translational Science Institute (CTSI); Boston, MA              July 2016 – May 21, 2017

TL1 Fellowship, Certificate Degree in Clinical & Translational Science
- Top 25% Poster Award, Translational Science Annual Meeting, Washington D.C. (2017)             

- Burroughs Wellcome Fund Travel Award, Translational Science (2017)

Western New England University (WNEU); Springfield, MA                                Aug 2009 – May 2013

Bachelor of Science - Biology and Chemistry double major                                             

- Graduated Summa Cum Laude

- Biology Achievement Award (2013)                                     

- Chemistry Book Prize (2013)                                                  

RESEARCH EXPERIENCE

Clinical Scholars Track Research Fellow, Stanford Dermatology                                   July 2020 - 2022

      PIs: Sumaira Aasi, MD and Nour Kibbi, MD

• Performed a retrospective analysis of the rate of upstaging of melanoma during Mohs micrographic surgery at Stanford and described the implications of upstaging on patient treatment and outcomes. Abstract accepted to the American College of Mohs Surgery Virtual Annual Meeting, May 5-9, 2021.
• Clinical outcomes in sebaceous carcinoma: a multicenter retrospective analysis. Manuscript currently in preparation.

PIs: Susan Swetter, MD and Alan Geller, MPH, RN

• Analyzed 2015-2019 American Academy of Dermatology’s SPOT Skin Cancer® national screening program data and authored 2 manuscripts.

TL1 Research Fellow, Tufts CTSI & Massachusetts General Hospital                    July 2016 – June 2017

PIs: Alan Geller, MPH, RN and Hensin Tsao, MD, PhD

• Compiled and organized a database of over 2.1 million screening forms from the American Academy of Dermatology’s SPOT Skin Cancer® national screening program (1985-2014).
• Published four manuscripts and presented the findings at local and national conferences.

PI: Hensin Tsao, MD, PhD

• Extracted data from roughly 400 pathology reports of biopsy-proven melanomas for a publication surrounding the clinical spectrum of cutaneous melanomas.

PEER-REVIEWED PUBLICATIONS

Gao D.X., Swetter S.M., Hawryluk E.B., Geller A.C., Beaulieu D. Screening motivations among participants of the American Academy of Dermatology's SPOT Skin Cancer screening program from 2018 to 2019: A cross-sectional analysis. Journal of the American Academy of Dermatology. 2022; S0190-9622(22)02244-7. doi: 10.1016/j.jaad.2022.06.1194

Beaulieu D., Gao D.X., Swetter S.M., Hawryluk E.B., Geller A.C. Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer® screening program - A cross-sectional analysis. Journal of the American Academy of Dermatology 2021; S0190-9622(21)01044-6. doi:10.1016/j.jaad.2021.05.048

Beaulieu D., Nord K. An atypical presentation of pretibial myxedema in a euthyroid patient with absent antithyroid autoantibodies. JAAD Case Reports. 2021;12:88-90. doi:10.1016/j.jdcr.2021.04.018

Beaulieu D., Tsao H., Michaud D.S., Okhovat, J.P., Halpern, A.C., Geller, A.C. A Geographically-Based   Cross-Sectional Analysis of SPOT me® Skin Cancer Screening Data. Journal of the American            Academy of Dermatology 2021; S0190-9622(20)31074-4. doi:10.1016/j.jaad.2020.06.014

Beaulieu, D., Tsao, H., Michaud, D.S., Okhovat, J.P., Halpern, A.C., Geller, A.C. Number needed to          screen (NNS) for presumptive screening diagnoses among first-time SPOTme screening          participants (1992-2010). Journal of the American Academy of Dermatology 2020; pii: S0190-           9622(19)30991-0. doi: 10.1016/j.jaad.2019.06.027

Beaulieu, D., Fathi, R., Adnan, M., Nijhawan, R.I. Spiradenocarcinoma Treated with Mohs Micrographic    Surgery. Dermatologic Surgery 2019; 0:1-3. doi: 10.1097/DSS.0000000000001534

Klebanov, N., Gunasekera, N., Lin, W., Hawryluk, E., Miller, D.M., Reddy, B.Y., Christman, M.P.,    Beaulieu, D., Rajadurai, S., Sober, A.J., Tsao, H. The Clinical Spectrum of Melanoma        Morphology. Journal of the American Academy of Dermatology 2019; 80(1):178-188.e3. doi:   10.1016/j.jaad.2018.08.028

Beaulieu, D., Tsao, H., Michaud, D.S., Okhovat, J.P., Halpern, A.C., Geller, A.C. Factors associated         with suspected keratinocyte carcinoma, dysplastic nevus, and cutaneous melanoma among          first-time SPOTme screening program participants (2009-2010). Journal of the American            Academy of Dermatology 2018; pii: S0190-9622(18)33052-4. doi: 10.1016/j.jaad.2018.12.010

Okhovat, J.P., Beaulieu, D.*, Tsao, H., Halpern, A.C., Michaud, D.S., Shaykevich, S., Geller, A.C. The           first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-          2014. Journal of the American Academy of Dermatology 2018. pii: S0190-9622(18)32047-4. doi: 10.1016/j.jaad.2018.05.1242 (*Co-first author)

Beaulieu, D., Fathi, R., Srivastava, D., Nijhawan, R.I. Current perspectives on Mohs micrographic     surgery for melanoma. Clinical, Cosmetic and Investigational Dermatology 2018; 11:309-320.         doi: 10.2147/CCID.S137513.

Beaulieu, D., Nijhawan, R.I. Cells to Surgery Quiz: February 2018. Journal of Investigative             Dermatology 2018; 138(2):e21. doi: 10.1016/j.jid.2017.12.012

Beaulieu, D., Nijhawan, R.I. The eyelid grid. Journal of the American Academy of Dermatology 2018;       78(3):e67-e68. doi: 10.1016/j.jaad.2017.09.045.

Aklujkar, M., Risso, C., Smith, J., Beaulieu, D., Dubay, R., Giloteaux, L., DiBurro, K., Holmes, D.       Anaerobic degradation of aromatic amino acids by the hyperthermophilic archaeon Ferroglobus    placidus. Microbiology 2014; 160:2694-2709. doi: 10.1099/mic.0.083261-0 
 

ORAL PRESENTATIONS

Beaulieu, D., Geller, A. Considerations for a risk-based screening approach. American Academy of Dermatology Melanoma/Skin Cancer Community Programs Committee virtual meeting. 2021, Oct 19.

Beaulieu, D. The American Academy of Dermatology’s SPOT me® Program at a Glance (1985-2014).     Melanoma Prevention Working Group virtual meeting. 2020, Nov 7.

Beaulieu, D. Non-Uremic Calciphylaxis – An Atypical Presentation of a Rare Entity. Stanford Dermatology Resident Case Symposium. 2020, Aug 27.

Beaulieu, D. Findings from the American Academy of Dermatology’s SPOTme Program: 1985-2014.       Massachusetts General Hospital Melanoma Lecture Series. Boston, MA. 2017, Jun 6.

Beaulieu, D. Risk Factors Associated with a Recent Change in Mole(s) Size, Shape, or Color among American Academy of Dermatology SPOTme Program Participants (2009-2010). American Academy of Dermatology Annual Meeting, F085 – Late-breaking Research Forum Basic Science/Cutaneous Oncology/Pathology. Orlando Convention Center. Orlando, FL. 2017, Mar 4.

Beaulieu, D. Selected Findings from the American Academy of Dermatology’s SPOTme Program (1985- 2014). American Academy of Dermatology Annual Meeting, Melanoma/Skin Cancer Community       Programs Committee Meeting. Orlando Convention Center. Orlando, FL. 2017, Mar 3.

POSTER PRESENTATIONS & RESEARCH ABSTRACTS

Beaulieu, D., Cohen, S., Aasi, S. Mohs Micrographic Surgery for Melanoma – A Retrospective Analysis of Upstaging and Clinical Outcomes at a Single Institution. American College of Mohs Surgery Annual Meeting. Virtual. 2021, May 5-9.

Beaulieu, D., Michaud, D.S., Okhovat, J.P., Shaykevich, S., Halpern, A.C., Tsao, H., Geller, A.C. Risk         Factors Associated with a Recent Change in Mole(s) Size, Shape, or Color among American           Academy of Dermatology SPOTme Program Participants (2009-2010). Translational Science      2017. Washington Marriott Wardman Park. Washington, DC. 2017, Apr 19.

Beaulieu, D., Shah, S., Baleja, J., Degterev, A. NMR Metabolomic Analysis of the Phosphatidylinositol-3   Kinase/Akt Signaling Pathway Inhibitor NCL-240 Reveals Unanticipated Effects on Human            Ovarian Carcinoma Cell Metabolism. Summer Research Poster Symposium. Tufts University    School of Medicine. Boston, MA. 2014, Nov 20.

RESEARCH FUNDING

NIH Award #TL1TR001062, National Center for Advancing Translational Sciences             2016 – 2017

Harold Williams Summer Research Fellowship, TUSM                                                   Summer 2014   

PROFESSIONAL INTERESTS

Mohs micrographic surgery, procedural dermatology, advanced reconstruction, skin cancer screening & prevention, dermatoepidemiology